Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. PROFEMUR® Z STEM; HIP COMPONENT
FDA Home
Medical Devices
Databases
-
510(k)
|
DeNovo
|
Registration & Listing
|
Adverse Events
|
Recalls
|
PMA
|
HDE
|
Classification
|
Standards
CFR Title 21
|
Radiation-Emitting Products
|
X-Ray Assembler
|
Medsun Reports
|
CLIA
|
TPLC
MICROPORT ORTHOPEDICS INC. PROFEMUR® Z STEM; HIP COMPONENT
Back to Search Results
Model Number
PHA0-0238
Medical Device Problem Code
Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code
No Information (3190)
Type of Reportable Event
Serious Injury
Event or Problem Description
Allegedly, patient was revised due to recurrent prosthesis dislocation.
Search Alerts/Recalls
New Search
|
Submit an Adverse Event Report
Brand Name
PROFEMUR® Z STEM
Common Device Name
HIP COMPONENT
Manufacturer
(Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key
9967993
Report Number
3010536692-2020-00343
Device Sequence Number
14563455
Product Code
LPH
UDI-Device Identifier
M684PHA002381
UDI-Public
M684PHA002381
Combination Product (Y/N)
N
Initial Reporter Country
IT
Number of Events Summarized
1
Summary Report (Y/N)
N
Device Implanted Year
2012
Device Explanted Year
2013
Reporter Type
Manufacturer
Report Source
health professional
Initial Reporter Occupation
Physician
Type of Report
Initial
Report Date
(Section B)
04/16/2020
1
Device was Involved in the Event
1
Patient was Involved in the Event
Is this an Adverse Event Report?
Yes
Is this a Product Problem Report?
No
Operator of Device
Health Professional
Device Model Number
PHA0-0238
Device Catalogue Number
PHA0-0238
Device Lot Number
1412210
Was Device Available for Evaluation?
No
Was the Report Sent to FDA?
No
Distributor Facility Aware Date
03/25/2019
Type of Report(Section G)
Thirty-Day
Initial Date Received by Manufacturer
03/25/2019
Initial Report FDA Received Date
04/16/2020
Patient Sequence Number
1
Outcome Attributed to Adverse Event
Required Intervention;
Patient Age
79 YR
-
-